Company Filing History:
Years Active: 2024
Title: Matthias Alexander Oberli: Innovator in Implantable Therapeutics
Introduction
Matthias Alexander Oberli is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of implantable therapeutic technologies. With a total of 2 patents, Oberli's work focuses on innovative solutions for treating various diseases and disorders.
Latest Patents
Oberli's latest patents include groundbreaking inventions that enhance the efficacy of therapeutic agents. One of his patents, titled "Implantable particles and related methods," describes particles that consist of a first compartment, a second compartment, and a compound of Formula (I). These particles may include a cell capable of expressing a therapeutic agent useful for treating specific diseases, disorders, or conditions. Another patent, "Compounds, devices, and uses thereof," provides compounds, including those of Formula (I) and their derivatives. This invention also encompasses implantable elements, such as devices and materials, along with methods for their use in treating or preventing various health issues.
Career Highlights
Oberli is currently associated with Sigilon Therapeutics, Inc., where he continues to push the boundaries of medical technology. His work is characterized by a commitment to developing innovative solutions that can significantly improve patient outcomes.
Collaborations
Throughout his career, Oberli has collaborated with notable professionals in the field, including Omid Veiseh and Richard Heidebrecht. These collaborations have further enriched his research and development efforts, leading to advancements in therapeutic technologies.
Conclusion
Matthias Alexander Oberli stands out as a key figure in the realm of implantable therapeutics. His innovative patents and dedication to improving healthcare solutions underscore his impact on the industry.